Literature DB >> 10369517

Brain banking: basic science methods.

A C McKee1.   

Abstract

The fundamental objectives of a brain bank are to document precisely the gross anatomical and histological findings, to establish accurate neuropathological diagnoses using well-defined criteria and standardized dissection techniques, and to serve as a source of fresh, fixed, and deep-frozen brain tissue. The brain tissue is optimally prepared and stored to provide high-quality research material that is suitable for a wide variety of investigations. A computerized database is used to classify all clinical and pathological diagnoses, neuropathological data, cause of death, postmortem interval, associated chronic diseases, and storage conditions of the tissue. Tissue availability and distribution is monitored and quality assurance is provided regarding tissue acquisition, processing, storage, and diagnosis. These functions facilitate clinicopathological correlative studies, neurochemical, molecular biological, immunohistochemical, quantitative and in vitro studies. Furthermore, the use of standardized tissue methods promotes multicenter collaborations.

Entities:  

Mesh:

Year:  1999        PMID: 10369517

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  3 in total

1.  Severe impairment of circadian rhythm in Alzheimer's disease.

Authors:  L Volicer; D G Harper; E G Stopa
Journal:  J Nutr Health Aging       Date:  2012-10       Impact factor: 4.075

2.  Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia.

Authors:  David G Harper; Edward G Stopa; Victoria Kuo-Leblanc; Ann C McKee; Kentaro Asayama; Ladislav Volicer; Neil Kowall; Andrew Satlin
Journal:  Brain       Date:  2008-03-27       Impact factor: 13.501

3.  Noninvasive fractal biomarker of clock neurotransmitter disturbance in humans with dementia.

Authors:  Kun Hu; David G Harper; Steven A Shea; Edward G Stopa; Frank A J L Scheer
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.